About Contact Us Careers

Omeprazole Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 2477
Published Date: Jul 23, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Omeprazole Landscape

Boehringer Ingelheim
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
AstraZeneca Plc.
Azurity Pharma
Perrigo Company Plc.
Salix pharmaceuticals

Browse Key Market Insights with Data Illustration:

Omeprazole Market Size & Share | Growth Forecasts 2036

In the News

Perrigo Company, a leading supplier of consumer health products announces today that the US Food and Drug Administration has given final clearance for omeprazole magnesium delayed mini capsules, 20mg OTC. Perrigo is planning to make Omeprazole Minis available in the latter part of this year.
AstraZeneca announced to sell omeprazole and its associated brand's global commercial rights to Cheplapharm Arzneimittel GmbH.

Author Credits: Radhika Pawar

Report ID: 2477
Published Date: Jul 23, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of omeprazole is estimated at USD 1.12 Billion.

The omeprazole market size was valued at USD 1.06 Billion in 2023 and is expected to cross USD 2.38 Billion by the end of 2036, expanding at more than 6.4% CAGR during the forecast period i.e., between 2024-2036. Increasing cases of gastroesophageal reflux, increasing awareness among people, and increasing prevalence of duodenal ulcers.

Asia Pacific industry will hold a share of 28.6% by 2036, driven by greater awareness amongst target audiences about treating this condition, growing incidences, and intensified focus of key players to increase their product portfolio in the region.

Boehringer Ingelheim, AstraZeneca Plc., Azurity Pharma, Perrigo Company Plc., Salix pharmaceuticals

Inquiry Before Buying Request Free Sample